IMPACT OF THE INTERNATIONAL REFERENCE PRICING ON ACCESS TO STANDARD THERAPY DRUGS FOR ASTHMA AND COPD

被引:0
|
作者
Visnansky, M. [1 ]
Kababikova, D. [1 ]
机构
[1] Univ Vet Med & Pharm Kosice, Kosice, Slovakia
关键词
D O I
10.1016/j.jval.2016.09.1234
中图分类号
F [经济];
学科分类号
02 ;
摘要
PRS64
引用
收藏
页码:A560 / A560
页数:1
相关论文
共 45 条
  • [1] IMPACT OF THE INTERNATIONAL REFERENCE PRICING ON ACCESS TO STANDARD THERAPY DRUGS FOR COPD
    Visnansky, M.
    Butalova, A.
    VALUE IN HEALTH, 2018, 21 : S415 - S416
  • [2] International reference pricing for prescription drugs: a landscape analysis
    Rand, Leah Z.
    Kesselheim, Aaron S.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (09): : 1309 - 1313
  • [3] THE IMPACT OF VALUE-BASED PRICING (VBP) VS INTERNATIONAL REFERENCE PRICING (IRP) ON INNOVATIVE DRUGS IN THE US
    Labban, M.
    Patrick, A.
    Lederer, Mahendraratnam N.
    Jao, R.
    Patel, P.
    Jaksa, A.
    VALUE IN HEALTH, 2022, 25 (07) : S364 - S364
  • [4] IMPACT OF GREXIT ON PHARMACEUTICAL PRICING: AN INTERNATIONAL REFERENCE PRICING ANALYSIS
    Weiss, J.
    Hakim, P.
    Kjeldgaard-Pedersen, J.
    Degun, R.
    Walsh, K.
    VALUE IN HEALTH, 2015, 18 (07) : A701 - A701
  • [5] Mucoactive drugs for asthma and COPD: any place in therapy?
    Rogers, DF
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (01) : 15 - 35
  • [6] POLICY CHANGES AND IMPACT ON PRICING AND ACCESS OF DRUGS IN US
    Patel, D.
    Gaba, D.
    Shah, S.
    VALUE IN HEALTH, 2019, 22 : S301 - S301
  • [7] Estimated Savings From International Reference Pricing for Prescription Drugs
    Mulcahy, Andrew W.
    Schwam, Daniel
    Rao, Preethi
    Rennane, Stephanie
    Shetty, Kanaka
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (17): : 1744 - 1745
  • [8] IMPACT OF INTERNATIONAL REFERENCE PRICING ON FIVE PRODUCTS IN THE USA
    De Cristofano, F.
    Barling, H.
    VALUE IN HEALTH, 2019, 22 : S299 - S299
  • [9] PROPOSED US INTERNATIONAL REFERENCE PRICING, POSSIBLE IMPACT
    Mycka, J.
    Lobb, W.
    Dellamano, R.
    Dalal, N.
    Pereira, E.
    Dellamano, L.
    VALUE IN HEALTH, 2020, 23 : S300 - S300
  • [10] US REFERENCE PRICING IMPACT ON TRANSPARENCY, PRICING, AND ACCESS IN THE EU4 FINAL
    Patel, K.
    Ahmad, M.
    Shah, S.
    VALUE IN HEALTH, 2022, 25 (12) : S104 - S104